tirzepatide phoenix Semaglutide In Scottsdale, AZ Medical Weight Loss Programs Phoenix

Tirzepatide is a novel medication approved by the FDA for the treatment of type 2 diabetes (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)

The conversion between the two medications is not straightforward because they target different receptor combinations

The goal shifts from weight loss to weight maintenance and continued metabolic health

Although some animal studies have suggested that semaglutide may have an anti-inflammatory effect outside of weight loss, the improvement in pain is likely due to weight loss rather than any anti-inflammatory effects of the medication, Felson said

Mounjaro and Zepbound both contain tirzepatide, a dual GIP and GLP-1 receptor agonist